FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease-Reference-Cited by-同舟云学术

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease

Published:2018 Issue: Volume:20 Page:572-579
ISSN:2213-1582
Container-title:NeuroImage: Clinical
language:en
Short-container-title:NeuroImage: Clinical

Author:

Matthews Dawn C.^ORCID,Lerman Hedva,Lukic Ana,Andrews Randolph D.,Mirelman Anat,Wernick Miles N.,Giladi Nir,Strother Stephen C.,Evans Karleyton C.,Cedarbaum Jesse M.,Even-Sapir Einat

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology,Radiology, Nuclear Medicine and imaging

Reference43 articles.

1. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET;Berding;Mov. Disord.,2001

2. Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease;Berti;J. Nucl. Med. Mol. Imaging.,2012

3. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia;Bohnen;Neurology,1999

4. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study;Bohnen;J. Nucl. Med.,2011

5. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores;Carson;Int. J. Geriatr. Psychiatry.,2018

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal neuroimaging to characterize symptom-specific networks in movement disorders;npj Parkinson's Disease;2024-08-14

2. Age-related energetic reprogramming in glial cells: possible correlations with Parkinson’s disease;Ageing and Neurodegenerative Diseases;2024-07-17

3. Dysfunction of motor cortices in Parkinson’s disease;Cerebral Cortex;2024-07

4. Quantifying cerebral blood flow changes using arterial spin labeling: A comparative study of idiopathic rapid eye movement sleep behavior disorder and Parkinson's disease;Magnetic Resonance Imaging;2024-06

5. How Lifetime Evolution of Parkinson’s Disease Could Shape Clinical Trial Design: A Shared Patient–Clinician Viewpoint;Brain Sciences;2024-04-03